SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583771-21-000004
Filing Date
2021-05-14
Accepted
2021-05-14 16:55:59
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20210331.htm   iXBRL 10-Q 945841
2 EX-31.1 hepa-2021033110qxexx311.htm EX-31.1 9926
3 EX-31.2 hepa-2021033110qxexx312.htm EX-31.2 9458
4 EX-32.1 hepa-2021033110qxexx321.htm EX-32.1 4765
5 EX-32.2 hepa-2021033110qxexx322.htm EX-32.2 4428
11 hepa-20210331_g1.jpg GRAPHIC 10809
  Complete submission text file 0001583771-21-000004.txt   5584014

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hepa-20210331.xsd EX-101.SCH 44469
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hepa-20210331_cal.xml EX-101.CAL 61578
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hepa-20210331_def.xml EX-101.DEF 261030
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hepa-20210331_lab.xml EX-101.LAB 532488
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hepa-20210331_pre.xml EX-101.PRE 379585
12 EXTRACTED XBRL INSTANCE DOCUMENT hepa-20210331_htm.xml XML 823158
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 21925626
SIC: 2834 Pharmaceutical Preparations